Have you read this week´s Navigator updates? In it, we share key updates on several new and ongoing clinical trials for #myeloma that have been added to the #MPENavigator. Read the update here: navigator.mpeurope.org/en/news/new-tr… Find trials on the Navigator here: navigator.mpeurope.org/en/trials/find…

Join MPE’s European #YoungMyelomaPatients Group! You will find: 👥A platform for under-55s to share, support and exchange resources. 🎓 Quarterly webinars led by experts. 💬 A Facebook group where you can connect with peers. Learn more about it here: mpeurope.org/european-young…

Meet William Kenneth Casler a #MyelomaPatient who was diagnosed with myeloma in 2009, Kenneth went through multiple treatments that led him to CAR T-cell therapy. 🔗Read more about his story here: mpeurope.org/living-with-my… #PatientStories #Myeloma #CART

📢New MPE article published in International Clinical Trials magazine: "Addressing multiple #myeloma and #ALAmyloidosis patient information gaps on clinical trials in Europe" explains the challenges patients face in accessing clinical trial information. calameo.com/read/006113385…

Have you read this week´s Navigator updates? In it, we share key updates on several new and ongoing clinical trials. Read the Week 34 updates of the MPE Navigator here: navigator.mpeurope.org/en/news/new-tr… 👉 Find more trials on the Navigator here: navigator.mpeurope.org/en/trials/find…

Take a look at our latest research report on the challenges faced by working-age adults living with #myeloma. This study covers the unmet needs of myeloma patients, who need to balance work, family and treatment. 💻Download here: mpeurope.org/what-we-do/res…

Subscribe to MPE's newsletter! 📰 Stay up today with the latest #myeloma and #ALAmyloidosis news, as well as all the MPE activities: mpeurope.org/subscribe-to-m…

Have you read this week´s Navigator updates? In it, we share key updates on several new and ongoing clinical trials. navigator.mpeurope.org/en/news/new-tr… Find more trials on the Navigator here: navigator.mpeurope.org/en/trials/find…

🩸 September is #BloodCancerAwarenessMonth! During this month, MPE will be highlighting the challenges patients face around #ClinicalTrials. Join us on the 27 of September for #EuropeanMyelomaDay. Learn more about QoL in #MyelomaClinicalTrials here: mpeurope.org/what-we-do/res…

MPE created the #Myeloma Patient Guide that provides answers to questions you may have about myeloma. Learn how it may affect you, what treatments you may have and much more. Download the MPE myeloma patient's guide: mpeurope.org/about-myeloma/

In preparation for #EuropeanMyelomaDay on September 27th, MPE is highlighting the crucial role of clinical trials and advocating for improved patient access across Europe during #BloodCancerAwarenessMonth. Download our editable files! mpeurope.org/european-myelo… #LearnShareChange

Minimal Residual Disease (MRD) also called measurable residual disease refers to a very small number of cancer cells that remain in the body during or after treatment. You can learn more about #MRD here: mpeurope.org/what-we-do/res…

Living with #myeloma as a patient under 55 years old can present unique challenges. MPE created the European Young Myeloma Patients group to highlight the experiences and needs of these patients. Join the MPE #YoungMyelomaPatients group here: mpeurope.org/european-young…

🚴‍♂️Team MPE is supporting today's #RajdPoZdrowie bike event organised by our member, Fundacja Carita im. Wiesławy Adamiec in Poznan, Poland. This event brings together patients, healthcare professionals and supporters.

📅 #EuropeanMyelomaDay 2024 is on September 27th! This year, we are highlighting the crucial role of clinical trials and advocating for improved patient access across Europe. Check out our social media toolkit on the MPE website: mpeurope.org/european-myelo… #LearnShareChange

Explore the MPE #Myeloma and #ALAmyloidosis European Clinical Trial Navigator. In it you will find information on #ClinicalTrials matching your criteria, from specific hospitals to disease stages. navigator.mpeurope.org/en #MPENavigator

Learn about #CART, an innovative form of immunotherapy for #myeloma by exploring the MPE myeloma CAR-T treatment resource page on our website. Access: 🔍Q&A's 📑Factsheets 💬Webinars and interviews 🔬Research projects mpeurope.org/car-t-cell-the…

Spotlight on Myeloma: Cancer of plasma cells. Often diagnosed in later stages. Symptoms may include bone pain and fatigue. #MyelomaAwareness #bloodcancerawarenessmonth #bcam #september Acute Leukemia Advocates Network (ALAN) CLL Advocates Network CML AdvocatesNetwork Myeloma Patients Europe Lymphoma Coalition MDS Alliance MPNAdvocatesNetwork

Have you read this week´s Navigator updates? In it, we share key updates on several new and ongoing clinical trials. Read week 37 update here: navigator.mpeurope.org/en/news/new-tr… 👉 Find more trials on the Navigator here: navigator.mpeurope.org/en/trials/find… #ClinicalTrials #MPENavigator

Help spread awareness online about the important role clinical trials play in the lives of #MyelomaPatients and join us on 27 September for #EuropeanMyelomaDay! Click on the link and download our editable social media graphics: mpeurope.org/european-myelo… #LearnShareChange